SHEL.UK

3,141.25

-0.39%↓

BP

538.5

-1.57%↓

SHEL.UK

3,141.25

-0.39%↓

BP

538.5

-1.57%↓

SHEL.UK

3,141.25

-0.39%↓

BP

538.5

-1.57%↓

SHEL.UK

3,141.25

-0.39%↓

BP

538.5

-1.57%↓

SHEL.UK

3,141.25

-0.39%↓

BP

538.5

-1.57%↓

Начало・Списък с акции・Smith & Nephew PLC
Search

Smith & Nephew PLC

Отворен

1,148 1.23

Купи

Обновена цена 1.05.2026 г., 15:29 ч. UTC

КупиПродай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1146

Максимум

1154

Ключови измерители

By Trading Economics

Приходи

47M

342M

Продажби

318M

3.3B

P/E

Средно за сектора

20.16

69.28

EPS

0.429

Дивидентна доходност

3.64

Марж на печалбата

10.36

Служители

16,988

EBITDA

162M

886M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+27.95% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

3.64%

3.44%

Следващи печалби

4.08.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-2B

9.1B

Предишно отваряне

1146.77

Предишно затваряне

1148

Smith & Nephew PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

13.05.2026 г., 22:54 ч. UTC

Печалби

Xero Lifts Annual Earnings 18%, Flags More Growth Ahead

DJ

Прочетени

13.05.2026 г., 23:51 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

DJ

Прочетени

13.05.2026 г., 23:51 ч. UTC

Пазарно говорене

Australian Consumer Spending Is Holding Up; RBA Watching -- Market Talk

DJ

Прочетени

13.05.2026 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Rise After Overnight U.S. Tech Gains -- Market Talk

DJ

Прочетени

13.05.2026 г., 23:45 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

DJ

Прочетени

13.05.2026 г., 23:17 ч. UTC

Печалби

Samsung Fire & Marine Insurance 1Q Net Profit Beat FactSet-Compiled Consensus

DJ

Прочетени

13.05.2026 г., 23:16 ч. UTC

Печалби

Samsung Fire & Marine Insurance 1Q Net KRW635.22B Vs. Net KRW609.03B >000810.SE

DJ

Прочетени

13.05.2026 г., 23:15 ч. UTC

Печалби

Samsung Fire & Marine Insurance 1Q Oper Pft KRW861.13B Vs. Pft KRW792.36B >000810.SE

DJ

Прочетени

13.05.2026 г., 23:14 ч. UTC

Печалби

Samsung Fire & Marine Insurance 1Q Rev KRW6.676T Vs. KRW6.106T >000810.SE

DJ

Прочетени

13.05.2026 г., 23:02 ч. UTC

Пазарно говорене
Печалби

Cisco Product Demand Climbing Even Without Hyperscalers -- Market Talk

DJ

Прочетени

13.05.2026 г., 22:59 ч. UTC

Пазарно говорене
Печалби

Cisco Boosted by Tech Infrastructure Upgrade Cycle -- Market Talk

DJ

Прочетени

13.05.2026 г., 22:24 ч. UTC

Печалби

Xero FY U.S. Organic Revenue Growth 30%>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:23 ч. UTC

Печалби

Xero FY International Organic Revenue Growth 25%>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:23 ч. UTC

Печалби

Xero FY International Revenue Growth 47%>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:22 ч. UTC

Печалби

Xero FY Australia, New Zealand Revenue Up 18% on Year >XRO.AU

DJ

Прочетени

13.05.2026 г., 22:19 ч. UTC

Печалби

Xero FY Australia, New Zealand Revenue Up 17% in Constant Currency>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:19 ч. UTC

Печалби

Xero FY Net Customer Additions 506,000 Vs. 254,000>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:18 ч. UTC

Печалби

Xero FY Rule of 40: 48.5% Vs. 44.3%>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:16 ч. UTC

Печалби

Xero: Ebitda Guidance Includes NZD55M of Incremental U.S. Brand Spend>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:15 ч. UTC

Печалби

Xero Expects FY27 Adjusted Ebitda of NZD860M-NZD920M>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:15 ч. UTC

Печалби

Xero Expects FY27 Operating Revenue of NZD3.62B-NZD3.73B>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:13 ч. UTC

Печалби

Xero FY Operating Expenses 70.5% of Operating Revenue Vs. 71.8%>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:12 ч. UTC

Печалби

Xero FY Free Cash Flow NZD554.0M Vs. NZD506.7M>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:11 ч. UTC

Печалби

Xero FY Adjusted Ebitda NZD757.4M Vs. NZD641.8M>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:11 ч. UTC

Печалби

Xero FY Ebitda NZD789.5M Vs. NZD638.5M>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:10 ч. UTC

Печалби

Xero Did Not Declare a Dividend>XRO.AU

DJ

Прочетени

13.05.2026 г., 22:10 ч. UTC

Печалби

Xero FY Rev NZD2.75B Vs. NZD2.10B >XRO.AU

DJ

Прочетени

13.05.2026 г., 22:09 ч. UTC

Печалби

Xero FY Net NZD167.4M Vs. Net NZD227.8M >XRO.AU

DJ

Прочетени

13.05.2026 г., 22:00 ч. UTC

Печалби

Cisco to Shed Jobs for All-In AI Push -- Update

DJ

Прочетени

13.05.2026 г., 21:11 ч. UTC

Печалби

Cisco Earnings and Revenue Beat Estimates on Strong AI Demand. Its Shares Surge. -- Barrons.com

DJ

Прочетени

Сравнение с други в отрасъла

Ценова промяна

Smith & Nephew PLC Прогноза

Ценова цел

By TipRanks

27.95% нагоре

12-месечна прогноза

Среден 1,411.25 GBX  27.95%

Висок 1,700 GBX

Нисък 959.757 GBX

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Smith & Nephew PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

7 ratings

4

Купи

3

Задържане

0

Продай

Според 7 анализатори, дали борсови рейтинги на Smith & Nephew PLC през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Други акции от сектора

SHEL.UK

Shell PLC

3,141.25

↓-0.39%

BPUS

BP PLC ADR

538.5

↓-1.57%
help-icon Live chat